logo-loader
viewCellmid Limited

Cellmid appoints Dr Dominic Burg as chief operating officer from July 1

Prior to joining Cellmid Dr Burg received his PhD from the University of New South Wales

Cellmid Limited - Cellmid appoints Dr Dominic Burg as chief operating officer from July 1
Dr Burg has been a key driver of the evolis® consumer brand (photo courtesy: hairbiology.org)

Cellmid Limited (ASX:CDY) has appointed Dr Dominic Burg as chief operating officer (COO) effective July 1 2020.

A key member of the Cellmid executive team, Dr Burg joined the company in March 2016 and has previously held positions as vice president of operations and director of operations.

Dr Burg has been instrumental in Cellmid’s growth, fulfilling a broad mandate to improve operational efficiencies across the company’s consumer and biotechnology businesses.

Expanding operations to the USA, Europe and Asia, Dr Burg has been a key driver of the evolis® consumer brand.

PhD from UNSW

Prior to joining Cellmid Dr Burg received his PhD from the University of New South Wales and had an academic career spanning more than ten years.

His post-doctoral appointments in Australia and abroad utilised his expertise in systems biology, and biomarkers of chronic and inflammatory diseases.

Cellmid CEO Maria Halasz said: “Dominic is an exceptional professional with whom I had the pleasure of working for the past four years.

“He is highly respected by all of us at Cellmid, our employees, directors, and partners.

“I am very much looking forward to working with Dominic in a more strategic role”

China sales back on track

Cellmid felt the impacts from the COVID-19 pandemic on sales growth during the March quarter but is confident that Chinese export sales will improve in the near-term.

Consumer health sales into China are getting back on track with the Chinese order for Lexilis® products of $685,000, delayed from first half of FY2020, now paid and on track to be delivered.

Quick facts: Cellmid Limited

Price: 0.14 AUD

ASX:CDY
Market: ASX
Market Cap: $17.53 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cellmid Limited named herein, including the promotion by the Company of Cellmid Limited in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cellmid Limited to supply rapid diagnostic tests to help in new pandemic

Cellmid Limited (ASX:CDY) CEO Maria Halasz tells Proactive's Andrew Scott they've signed an agreement to supply rapid diagnostic tests (RDT), with products expected to arrive in the country by early April. The test uses a virus-specific detection method that delivers results anywhere between...

on 30/3/20

2 min read